Super-resolution Multispectral Imaging Nanoimmunosensor for Simultaneous Detection of Diverse Early Cancer Biomarkers
Cancer Detection
Cancer Imaging
DOI:
10.1021/acssensors.4c00752
Publication Date:
2024-07-04T03:04:35Z
AUTHORS (3)
ABSTRACT
In medical diagnosis, relying on only one type of biomarker is insufficient to accurately identify cancer. Blood-based multicancer early detection can help more than cancer from a single blood sample. this study, super-resolution multispectral imaging nanoimmunosensor (srMINI) based three quantum dots (QDs) different color conjugated with streptavidin was developed for the simultaneous screening various biomarkers in at single-molecule level. experiment, srMINI chip used simultaneously detect key biomarkers: carcinoembryonic antigen (CEA), C-reactive protein (CRP), and alpha-fetoprotein (AFP). The exhibited 108 times higher sensitivity 0.18–0.5 ag/mL (1.1–2.6 zM) these commercial enzyme-linked immunosorbent assay kits because absence interfering signals substrate, establishing considerable potential multiplex blood. Therefore, using high diagnostic precision accuracy expected play decisive role diagnosis or community as biosensor.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (51)
CITATIONS (6)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....